ReviewFrontiers in medicine2026
The immunometabolic mechanisms and therapeutic targets of metabolic dysfunction-associated steatohepatitis.
Jiang Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it